Ethical, legal and economic issues raised by the use of human tissue in postgenomic research

Digestive Diseases

Volumn 20, Issue 3-4, 2002, Pages 257-265

  Reymond, Marc A ^a,c   Steinert, R ^b   Escourrou, J ^b   Fourtanier, G ^b  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Ethics; Human tissue; Legal and economic issues; Postgenomic research

Indexed keywords

BIOSAFETY; BIOTECHNOLOGY; DATA BASE; DRUG INDUSTRY; ECONOMIC ASPECT; ETHICS; GENOME; HUMAN; HUMAN RIGHTS; HUMAN TISSUE; LEGAL ASPECT; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; WORLD HEALTH ORGANIZATION;

BIOMEDICAL AND BEHAVIORAL RESEARCH; GENETICS AND REPRODUCTION;

CULTURE TECHNIQUES; ETHICS, RESEARCH; EUROPEAN UNION; HUMANS; TISSUE BANKS; UNITED STATES;

EID: 0036972405     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067677     Document Type: Review

References (24)

1. www.Biosample.com
2. Lawrence SC: Beyond the grave - The use and meaning of human body parts: A historical introduction; in Weir RF (ed): Stored Tissue Samples. Ethical, Legal and Public Policy Implications. Iowa City, University of Iowa Press, 1998, pp 111-142.
3. Gottlieb K: Human biological samples and the laws of property: The trust as a model for biological respositories; in Weir RF (ed): Stored Tissue Samples. Ethical, Legal and Public Policy Implications. Iowa City, University of Iowa Press, 1998, pp 182-197.
4. Office for Protection from Research Risks: 'Exculpatory Language' in Informed Consent. Cooperative Oncology Group Chairpersons Meeting November 15, 1996. http://ohrp. osophs.dhhs.gov/humansubjects/guidance/exculp.htm
5. Department of Health and Human Services: Basic HHS Policy for Protection of Human Research Subjects. Section 46.101, b (4); 56 FR 28003, June 18, 1991.
6. Naser CR: Research obligations to tissue and DNA sample sources; in Weir RF (ed): Stored Tissue Samples. Iowa City, Iowa University Press, 2001, pp 160-181.
7. CFR Part 56.
8. CFR Part 56, pp 101-124.
9. CFR Part 46, pp 107-117.
10. Windhover Information Inc., 2001.
11. National Blood Data Resource Center: http://www.nbdrc.org/
12. Feds to start real-time tracking of US blood supply. USA Today 08/20/2001. http://www.usatoday.com/news/healthscience/health/2001-08-20-blood- tracking.htm
13. Comité des Ministres aux Etats membres sur les banques de tissus humains: Recommandation No R(94)1: Santé et qualité de vie. http://www.social.coe.int/fr/QdeVie/recomm/r(94)1.htm
14. http://www.legifrance.gouv.fr/html/actualite/actualite_legislative/prepa/ bioethique.htm
15. http://www.legifrance.gouv.fr/html/actualite/actualite_legislative/prepa/ pl_bioethique2.htm
16. Schröder J, Taupitz J: Menschliches Blut: ver-wendbar nach Belieben des Arztes? Medizin in Recht und Ethik. Stuttgart, Enke, 1991.
17. Bundesministerium für Bildung und Forschung: Wie funktioniert die Forschungsförderung? http://www.bmbf.de/602_1428.html
18. Nuffield Council on Bioethics: Human Tissue: Removal of Tissue: Commercial Transactions. http://www.nuffieldbioethics.org/publications/humantissue/rep0000000191.asp
19. WHO Statistical Informations System: Fact Sheets on HIV/AIDS for Nurses and Midwives: Fact Sheet 12 Strategies for Prevention of HIV. http://www3.who.int/whosis/factsheets_hiv_nurses/fact-sheet-12/
20. The Straits Times, 5.4.02
21. WIPO: Treaties and Contracting Parties: Alphabetical list. http://www.wipo.org/treaties/sitemap/a-z.html
22. Convention on biological diversity: Convention Text. http://www.biodiv.org/convention/articles.asp
23. OECD: Biological Resource Centres: Underpinning the Future of Life Sciences and Biotechnology. http://www1.oecd.org/publications/e-book/9301041E.PDF
24. CDC: MMWR: Bioterrorism Alleging Use of Anthrax and Interim Guidelines for Management - United States, 1998. February 05, 1999/48(04), pp 69-74. http://www.cdc.gov/mmwr/preview/mmwrhtml/00056353.htm